These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 19428599

  • 21. Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models.
    Gowen BB, Wong MH, Jung KH, Smee DF, Morrey JD, Furuta Y.
    Antiviral Res; 2010 May; 86(2):121-7. PubMed ID: 19874853
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Extinction of West Nile Virus by Favipiravir through Lethal Mutagenesis.
    Escribano-Romero E, Jiménez de Oya N, Domingo E, Saiz JC.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848019
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo activities of anti-influenza virus compound T-705.
    Furuta Y, Takahashi K, Fukuda Y, Kuno M, Kamiyama T, Kozaki K, Nomura N, Egawa H, Minami S, Watanabe Y, Narita H, Shiraki K.
    Antimicrob Agents Chemother; 2002 Apr; 46(4):977-81. PubMed ID: 11897578
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.
    Jochmans D, van Nieuwkoop S, Smits SL, Neyts J, Fouchier RA, van den Hoogen BG.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4620-9. PubMed ID: 27185803
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells.
    Smee DF, Hurst BL, Egawa H, Takahashi K, Kadota T, Furuta Y.
    J Antimicrob Chemother; 2009 Oct; 64(4):741-6. PubMed ID: 19643775
    [Abstract] [Full Text] [Related]

  • 30. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
    Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV.
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
    [Abstract] [Full Text] [Related]

  • 31. The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
    Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J.
    PLoS One; 2013 Jun; 8(7):e68347. PubMed ID: 23874596
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106.
    Julander JG, Shafer K, Smee DF, Morrey JD, Furuta Y.
    Antimicrob Agents Chemother; 2009 Jan; 53(1):202-9. PubMed ID: 18955536
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug.
    Tanaka T, Kamiyama T, Daikoku T, Takahashi K, Nomura N, Kurokawa M, Shiraki K.
    Acta Virol; 2017 Jan; 61(1):48-55. PubMed ID: 28105854
    [Abstract] [Full Text] [Related]

  • 39. Synthesis of a Novel Class of 1,3-oxathiolane Nucleoside Derivatives of T- 705 and Evaluation of Their Anti-influenza A Virus and Anti-HIV Activity.
    Han M, Zhao X, Wu X, Huang W, Li X, Yu F.
    Med Chem; 2018 Jan; 14(6):595-603. PubMed ID: 29332597
    [Abstract] [Full Text] [Related]

  • 40. Mechanism of action of T-705 against influenza virus.
    Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K, Nomura N, Egawa H, Shiraki K.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):981-6. PubMed ID: 15728892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.